Mary L. Guye
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- Ferroptosis and cancer prognosis 1
- Gallbladder and Bile Duct Disorders 1
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Treatments and Studies 1
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Lily Lai (2 shared papers)Rebecca A. Nelson (2 shared papers)Thehang Luu (1 shared paper)Amy Tang (3 shared papers)Harry D. Bear (3 shared papers)Richard Hoefer (4 shared papers)Matthew P. Goetz (1 shared paper)Janet S. Winston (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)Annals of Surgical Oncology (1 paper)Cancers (1 paper)Cancer Research (1 paper)HPB (1 paper)
- Partner nations
- United States
In The Last Decade
Mary L. Guye
7 papers receiving 362 citations
Peers
Comparison fields: 5 of 49
- Cancer Research 129
- Oncology 117
- Pathology and Forensic Medicine 61
- Dermatology 23
- Pulmonary and Respiratory Medicine 53
Countries citing papers authored by Mary L. Guye
This map shows the geographic impact of Mary L. Guye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. Guye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. Guye more than expected).
Fields of papers citing papers by Mary L. Guye
This network shows the impact of papers produced by Mary L. Guye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. Guye. The network helps show where Mary L. Guye may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary L. Guye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 244 | |
| 2 | 2014 | 104 | |
| 3 | 2022 | 14 | |
| 4 | 2013 | 4 | |
| 5 | 2012 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2019 | 1 |
About Mary L. Guye
Mary L. Guye is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine and Gastroenterology, having authored 7 papers that have together received 371 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), HER2/EGFR in Cancer Research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Ferroptosis and cancer prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Gallbladder and Bile Duct Disorders (1 paper). The work is most often cited by research in Cancer Research (129 citations), Oncology (117 citations), Pathology and Forensic Medicine (61 citations), Dermatology (23 citations) and Pulmonary and Respiratory Medicine (53 citations). Mary L. Guye has collaborated with scholars based in United States. Frequent co-authors include Lily Lai, Rebecca A. Nelson, Thehang Luu, Amy Tang, Harry D. Bear, Richard Hoefer, Matthew P. Goetz, Janet S. Winston, Rick J. Jansen and Amber L. Collier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Surgical Oncology, Cancers, Cancer Research and HPB.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.